Heidelberg Pharma AG

Declaration of Voting Results & Voting Rights Announcements • Nov 27, 2017

News Details

Voting Rights Announcements | 27 November 2017 14:00

Heidelberg Pharma AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Heidelberg Pharma AG

27.11.2017 / 14:00

Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

---

Notification of Major Holdings

1. Details of issuerHeidelberg Pharma AG

Schriesheimer Str. 101

68526 Ladenburg

Germany

2. Reason for notification

	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
X	Change of breakdown of voting rights
X	Other reason: voluntary group disclosure relating to exceeding threshold at a subsidiaries level

3. Details of person subject to the notification obligation

Name:	City and country of registered office:
Mr Dietmar Hopp , Date of birth: 26 Apr 1940

4. Names of shareholder(s)

holding directly 3% or more voting rights, if different from 3.

dievini Hopp BioTech holding GmbH & Co. KG, DH-Holding Verwaltungs GmbH

5. Date on which threshold was crossed or reached:22 Nov 2017

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation	70.26 %	0.00 %	70.26 %	22452570
Previous notification	66.96 %	0.00 %	66.96 %	/

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN	absolute		in %
	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)
DE000A11QVV0	171538	15604389	0.76 %	69.50 %
Total	15775927		70.26 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
				%
		Total		%

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
					%
			Total		%

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least held 3% or more)	% of voting rights through instruments (if at least held 5% or more)	Total of both (if at least held 5% or more)
Zurechnungsstrang 1 – attribution of shares 1	%	%	%
Herr Dietmar Hopp	– %	– %	– %
DH-Holding GmbH & Co. KG	– %	– %	– %
DH-Holding Verwaltungs GmbH	4.17 %	– %	– %
Zurechnungsstrang 2 – attribution of shares 2	%	%	%
Herr Dietmar Hopp	– %	– %	– %
Hopp LT Vermögensverwaltung GmbH	– %	– %	– %
DH-Capital GmbH & Co. KG	– %	– %	– %
dievini Hopp BioTech holding GmbH & Co. KG	65.33 %	– %	65.33 %
Zurechnungsstrang 3 – attribution of shares 3	%	%	%
Herr Dietmar Hopp	– %	– %	– %
DH Verwaltungs GmbH	– %	– %	– %
DH-Capital GmbH & Co. KG	– %	– %	– %
dievini Hopp BioTech holding GmbH & Co. KG	65.33 %	– %	65.33 %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting:	% (equals voting rights)

10. Other explanatory remarks:

---

27.11.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	Heidelberg Pharma AG
	Schriesheimer Str. 101
	68526 Ladenburg
	Germany
Internet:	www.heidelberg-pharma.com

End of News	DGAP News Service